PMA device
Crystalens Accommodating Intraocular Lens & Trulign Toric Intraocular Lens
Bausch & Lomb, Inc. · Lens, Intraocular, Toric Optics (MJP, Class III) · First FDA decision Jul 27, 2016, newest Jul 27, 2016Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
5
Naming "Crystalens Accommodating"
MAUDE reports
465
Brand "Crystalens Accommodating", since 2015
PubMed studies
0
Mentioning "Crystalens Accommodating"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Crystalens Accommodating Intraocular Lens & Trulign Toric Intraocular Lens
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P030002-S038 · Decided Jul 27, 2016 · 177 days after receipt · Normal 180 Day Track
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Crystalens Accommodating", any status and sponsor, newest update first.
Bausch & Lomb IncorporatedNot on our public-company list
NCT01241279 · 6 participants · Start Oct 2010 · Primary completion Nov 2011
Device: Crystalens AO; SoftPort LI61AO · For: Cataract
Sites: Irvine, California
- Toric Intraocular Lens Following Cataract SurgeryPivotal-lookingCompleted
Bausch & Lomb IncorporatedNot on our public-company list
NCT01140477 · 229 participants · Start Jun 2010 · Primary completion Dec 2011
Device: Toric Accommodating Lens; Accommodating Lens · For: Cataract; Astigmatism
Sites: Bridgewater, New Jersey
Mark Packer, MD, FACSAcademic, hospital or other
NCT01275118 · 26 participants · Start Dec 2010 · Primary completion Sep 2011
Device: Tecnis Multifocal IOL; crystalens Accommodating IOL · For: Cataract
Sites: Eugene, Oregon
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Crystalens Accommodating", and for the whole product code for context.
This brand
465 reports: 1 malfunction, 463 injury, 0 death
Whole product code MJP
7,937 reports: 3,518 malfunction, 4,419 injury, 0 death
Newest reports for this brand
0001313525-2024-00128 · Received Jul 25, 2024 · Event dated May 9, 2024
Device type: Lens, Intraocular, Accommodative (NAA)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Capsular Contracture; Blurred Vision; Posterior Capsule Opacification
0001313525-2023-70104 · Received Sep 1, 2023 · Event dated Aug 24, 2017
Device type: Lens, Intraocular, Accommodative (NAA)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Capsular Contracture; Blurred Vision; Halo
0001313525-2023-70105 · Received Sep 1, 2023 · Event dated Sep 14, 2017
Device type: Lens, Intraocular, Accommodative (NAA)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Capsular Contracture; Blurred Vision; Halo
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0445-2012 · Started Nov 14, 2011 · Posted by FDA Jan 11, 2012
Reason given: Bausch + Lomb voluntary initiated the recall due to a physician complaint of haze on the Crystalens AO which was visualized using an angled beam from a slit lamp during the post-operative examination.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Lens, Intraocular, Accommodative (NAA)
Published research
The most relevant PubMed records for "Crystalens Accommodating"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MJP.
- TECNIS Toric 1-Piece Intraocular Lenses (IOL)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- Trulign Toric Posterior Chamber Intraocular LensBausch & Lomb, Inc. · PMA 2015
- Crystalens and Trulign Toric Intraocular Lenses (Iols)Bausch & Lomb, Inc. · PMA 2016
- enVista One-Piece Hydrophobic Acrylic Toric Intraocular Lens (Model MX60T)Bausch & Lomb, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.